Molecular Profiling and Decision Making in Breast Cancer: Clinical and Molecular Prognostic Information—Addressing Discordant Results
Release Date: December 30, 2008|
Expiration Date: December 30, 2009
Dec 11, 2008, Online Learning Series Program 4
Molecular Profiling and Decision Making in Breast Cancer: A Continual Online Learning Series is designed to provide sustained online learning for oncologists and other health care providers involved in the diagnosis and treatment of breast cancer. In the area of molecular profiling, the recent emergence of commercially available gene profiling tools, coupled with their variable degree of benefit balanced against the short- and long-term effects of chemotherapy, creates a pressing educational need for clinicians.
This educational activity is directed toward medical and surgical oncologists who counsel patients on therapeutic decisions following surgery for early-stage breast cancer. Other physicians, including pathologists, radiation oncologists, primary care physicians, and other health care providers, including nurses, pharmacists, and others who care for patients with breast cancer, are also invited to participate. No specific skills or knowledge other than a basic training in oncology is required for successful participation in this activity.At the conclusion of this activity, you should be able to:
CME credit will be granted for online participation only.
Successful completion is determined by a score of 75% or greater.